Elevance Health, Inc. (ETR:A58)
Germany
· Delayed Price · Currency is EUR 251.10
+0.40 (0.16%)
At close: Mar 5, 2026
Elevance Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Premiums & Annuity Revenue | 164,639 | 144,166 | 142,854 | 133,229 | 117,373 | Upgrade
|
| Total Interest & Dividend Income | 2,194 | 2,051 | 1,825 | 1,485 | 1,378 | Upgrade
|
| Other Revenue | 32,293 | 30,593 | 26,661 | 21,885 | 19,892 | Upgrade
|
| Total Revenue | 199,126 | 176,810 | 171,340 | 156,599 | 138,643 | Upgrade
|
| Revenue Growth (YoY) | 12.62% | 3.19% | 9.41% | 12.95% | 13.76% | Upgrade
|
| Policy Benefits | 148,223 | 127,567 | 124,330 | 116,642 | 102,571 | Upgrade
|
| Amortization of Goodwill & Intangibles | 628 | 580 | 885 | 767 | 441 | Upgrade
|
| Selling, General & Administrative | 41,978 | 38,800 | 36,236 | 30,728 | 26,604 | Upgrade
|
| Total Operating Expenses | 190,829 | 166,947 | 161,451 | 148,137 | 129,616 | Upgrade
|
| Operating Income | 8,297 | 9,863 | 9,889 | 8,462 | 9,027 | Upgrade
|
| Interest Expense | -1,403 | -1,185 | -1,030 | -855 | -802 | Upgrade
|
| EBT Excluding Unusual Items | 6,894 | 8,678 | 8,859 | 7,607 | 8,225 | Upgrade
|
| Merger & Restructuring Charges | -55 | -268 | -752 | -7 | -202 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 201 | - | - | - | Upgrade
|
| Asset Writedown | -129 | -41 | -392 | - | -7 | Upgrade
|
| Legal Settlements | - | -666 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -21 | Upgrade
|
| Pretax Income | 6,710 | 7,904 | 7,715 | 7,600 | 7,995 | Upgrade
|
| Income Tax Expense | 1,049 | 1,933 | 1,724 | 1,712 | 1,846 | Upgrade
|
| Earnings From Continuing Ops. | 5,661 | 5,971 | 5,991 | 5,888 | 6,149 | Upgrade
|
| Minority Interest in Earnings | 1 | 9 | -4 | 6 | 9 | Upgrade
|
| Net Income | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 | Upgrade
|
| Net Income to Common | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 | Upgrade
|
| Net Income Growth | -5.32% | -0.12% | 1.58% | -4.29% | 34.69% | Upgrade
|
| Shares Outstanding (Basic) | 224 | 232 | 236 | 240 | 244 | Upgrade
|
| Shares Outstanding (Diluted) | 225 | 233 | 237 | 243 | 247 | Upgrade
|
| Shares Change (YoY) | -3.56% | -1.90% | -2.22% | -1.62% | -2.95% | Upgrade
|
| EPS (Basic) | 25.28 | 25.81 | 25.38 | 24.56 | 25.26 | Upgrade
|
| EPS (Diluted) | 25.21 | 25.68 | 25.22 | 24.28 | 24.95 | Upgrade
|
| EPS Growth | -1.83% | 1.82% | 3.87% | -2.69% | 38.77% | Upgrade
|
| Free Cash Flow | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 | Upgrade
|
| Free Cash Flow Per Share | 14.13 | 19.55 | 28.50 | 29.85 | 29.48 | Upgrade
|
| Dividend Per Share | 6.840 | 6.520 | 5.920 | 5.120 | 4.520 | Upgrade
|
| Dividend Growth | 4.91% | 10.13% | 15.63% | 13.27% | 18.95% | Upgrade
|
| Operating Margin | 4.17% | 5.58% | 5.77% | 5.40% | 6.51% | Upgrade
|
| Profit Margin | 2.84% | 3.38% | 3.49% | 3.76% | 4.44% | Upgrade
|
| Free Cash Flow Margin | 1.59% | 2.57% | 3.95% | 4.63% | 5.25% | Upgrade
|
| EBITDA | 9,040 | 10,522 | 10,949 | 9,538 | 9,844 | Upgrade
|
| EBITDA Margin | 4.54% | 5.95% | 6.39% | 6.09% | 7.10% | Upgrade
|
| D&A For EBITDA | 743 | 659 | 1,060 | 1,076 | 817 | Upgrade
|
| EBIT | 8,297 | 9,863 | 9,889 | 8,462 | 9,027 | Upgrade
|
| EBIT Margin | 4.17% | 5.58% | 5.77% | 5.40% | 6.51% | Upgrade
|
| Effective Tax Rate | 15.63% | 24.46% | 22.35% | 22.53% | 23.09% | Upgrade
|
| Revenue as Reported | 199,125 | 177,011 | 171,340 | 156,595 | 138,639 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.